Please login to the form below
New Accounts: June - PR and medical education
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period March 2006 to May 2006 inclusive
The following tables list new pharmaceutical account wins notified to us by the winning
agencies for the period March 2006 to May 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
To submit an entry for New Accounts, email new_accounts@pmlive.com
|
|
|
|
|
|
The Alliance for Better Bone (P&G; S-A) |
Actonel |
Osteoporosis |
Ketchum |
|
ABPI |
The Involved Patient Initiative |
N/A |
Shire Health London |
|
Altana Pharma |
Pantoprazole |
Gastrointestinal |
Shire Health London |
|
Apitope Technology |
Phase Ib/IIa therapeutic biological vaccine |
MS |
Healthcare Solutions |
|
AstraZeneca |
Crestor |
Cardiovascular |
Zaicom MMC |
|
GlaxoSmithKline |
HPV vaccine |
Gynaecology/oncology |
Succinct Communications |
|
GlaxoSmithKline |
Telzir |
HIV |
90TEN Healthcare |
|
GrÈnenthal International |
Transtec - publications planning |
Pain |
Zaicom MMC |
|
Kimberly-Clark |
InteguSeal |
Antimicrobial surgical skin preparation |
De Facto Medica |
|
Link Pharmaceuticals |
Gliadel implant |
Oncology |
Spink Consumer Relations |
|
Merck SantÈ |
Glucovance |
Type II diabetes |
De Facto Medica |
|
NICE |
At Ri-SK? awareness campaign |
Solar keratosis |
hsdcommunications |
|
NICE |
Quick Reference Guides |
N/A |
90TEN Healthcare |
|
Pfizer |
Oncology portfolio |
Managed entry |
Succinct Communications |
|
Plethora/Timm |
Osbon ErecAid |
Male sexual dysfunction |
De Facto Medica |
|
ProStrakan |
Rapinyl |
Breakthrough pain |
Litmus/CCA |
|
Recordati |
Zanidip |
Cardiology |
LeapFrog Medical Communications |
|
Roche Pharmaceuticals |
Fuzeon/Invirase |
HIV |
Aurora |
|
Schering-Plough |
Nasonex |
Respiratory disease |
LeapFrog Medical Communications |
|
Servier |
Various |
Cardiology |
Zaicom MMC |
|
Speedel |
SPP301 |
Hypertension |
De Facto Medica |
|
UCB |
Professional development programme |
ADHD |
Huntsworth Health Avenue |
|
Wyeth Consumer Health |
Anadin |
Analgesics |
Spink Consumer Relations |
Share
Related Hub content
Featured jobs
-
Product Manager - Hertfordshire
-
Competitive salary depending on experience benefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
-
Senior Medical Writer
-
Great salary and bebefits
- CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...
-
EXCELLENT DAY RATES AVAILABLE
-
Director – Healthcare PR
-
Salary TBC
-
Scientific Engagement Director
-
Salary will be dependant on experience
- Assistant Product Manager - Hertfordshire
-
Competitive salary depending on experience benefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
-
Scientific Director
-
Great salary and bebefits
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Sales & Marketing Manager - New Launch - Mental Health - S E...
-
Highly Competitive Basic, Bonus &Benefits
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
-
Associate Director, Healthcare PR
-
£60, 000 – £67, 000+ benefits
Subscribe to our email news alerts
- Novo Nordisk expands cell therapy R&D, says type 1 diabetes cure a step closer
- Immuno-oncology at ASCO: survival data, combinations and new indications
- Novartis, Amgen set low price for first CGRP migraine drug
- Moving annual total (MAT)
- Key success factor (KSF)
- Janssen named ‘Pharma Company of the Year’ at business intelligence awards
- We can be heroes
- What does ‘digital’ look like for global pharma Learning & Development?
- FDA starts review of Sanofi’s oral type 1 diabetes drug
- Is the pharma business model ready for precision medicine?
- Porterhouse Medical announces another well-deserved promotion within the group
- FDA clears Dova drug for liver-related low blood platelets
PMHub
Swordfish Advertising
At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...
Latest intelligence
- Is the pharma business model ready for precision medicine?
- Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
- The NHS and ABPI at 70: inching closer to the triple win
- The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
- What pharma marketers can learn from behavioural science
- Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....
Quick links
Infographics
